INTRODUCTION
Monoclonal rheumatoid factors of the IgM type are found primarily in the blood of a proportion of patients with cryoglobulinemia. In their sera a monoclonal IgM component reacts, in the cold, with the polyclonal IgG giving a precipitate containing a mixture of IgM and IgG (1) . An antigenic analysis of the monoclonal IgM from different patients (2) has shown that they have cross-reacting idiotypes. On the basis of idiotype crossreactivity the rheumatoid factor cryoglobulins can be classified in a major group (Wa) that includes close to 60% of the patients, and a number of minor groups.
The impression has been widespread that the polyclonal rheumatoid factors, such as those that are in the blood of 60-80% of patients with active rheumatoid arthritis, are different from the monoclonal IgM anti-IgG immunoglobulins of the mixed cryoglobulinemias because their reaction with IgG has different pH and temperature requirements. The majority of patients with rheumatoid arthritis show little or no cryoglobulin.
On the other hand, recently Forre et al. (3) have published evidence that supports the existence of crossreacting idiotypes common to monoclonal and polyclonal rheumatoid factors. Our work has shown that plasma cells containing immunoglobulins that react with antibodies specific for the cross-reacting idiotypic determinants of the monoclonal rheumatoid factors of sub-group Wa are numerous in the synovial tissues of patients with rheumatoid arthritis. Furthermore, a relatively high percentage of cells that contain immunoglobulins that react with the same antibodies can be induced in vitro by cultivation of the peripheral blood lymphocytes from patients with active rheumatoid arthritis with pokeweed mitogen (PWM).' These cells were similar to those seen in PWM cultures of the lymphocytes from the blood of patients with cryoglobulinemia of the Wa group, although not as numerous.
It appears, therefore, that B cell clones idiotypically related to those of the monoclonal rheumatoid factors are numerous in the joint lesions of rheumatoid arthritis and also in the blood of patients with an active form of the disease. In this respect the human rheumatoid factor system appears to be characterized by cross-reacting idiotypes (CRI) that are found in different monoclonal immunoglobulins as well as in apparently polyclonal products. The major human rheumatoid factor CRI (RCRI) is, in this respect, similar to the CRI that are prominent in different mouse antibody systems such as the anti-dextran system (4), the anti-arsonate (Ars) system (5), and one antiallotype system (6) .
METHODS
Human cells. Eight active rheumatoid arthritis patients with high titer human IgG latex particle agglutination were studied for the production of CRI in pokeweed mitogen cultures. Two rheumatoid patients underwent synovectomies and cells from these synovia were also studied for the presence of CRI by indirect immunofluorescence. The synovial cell suspensions from these two patients as well as the peripheral blood of one of them were obtained through the courtesy of Dr. R. Winchester, Hospital for Joint Diseases, New York. The serological data of the rheumatoid arthritis patients as well as those of the five normal volunteers used as controls are given in Table I. In addition, the cells from two patients with cryoglobulinemia of the mixed type of the Wa group were studied. One of these patients (Glo) has been the subject of previous studies (7); the other patient (M.C.) was available through the courtesy of Dr. J. Lindenbaum, Columbia University, New York; the monoclonal IgM protein of this second patient Staining of plasma cells. 20 Ml of anti-RCRI antibodies at 150 ,g/ml were added to the PWM-induced plasma cells on the cytocentrifuge slides for 30 min at room temperature, followed by a 30-min wash in PBS, 0.01 M, pH 7.2. Sheep anti-rabbit immunoglobulin conjugated with fluorescein isothiocyanate was then applied to the same slide to stain RCRI-positive plasma cells as stated above. Sheep anti-rabbit immunoglobulin conjugated with fluorescein, when applied to slides not previously exposed to anti-RCRI antibodies gave no staining at all. The slides were again washed as before and finally, a goat anti-human immunoglobulin conjugated with tetraethyl rhodamine isothiocyanate was used to stain in direct immunofluorescence total plasma cells. Alternatively, goat anti-human mu and goat antihuman kappa conjugated with tetraethyl rhodamine isothiocyanate was used in direct immunofluorescence as a second stain.
Cohn Fraction II of human IgG (Miles Laboratories, Elkhart, IN) purified over DEAE 10 mm NaPB, pH 8.0, was conjugated with tetraethyl rhodamine isothiocyanate adjusted to 1 mg/ml and heat aggregated at 63°C for 10 min to prepare aggregates to counter stain RCRI-positive plasma cells in direct immunofluorescence. Fresh aggregates were prepared before each staining and spun at 9,000 g for 3 min at room temperature; the ability of each preparation to react with rheumatoid factor (RF) was checked by ring test in capillary tubes with'monoclonal RF.
In vitro inhibition of idiotype production. Rheumatoid mononuclear cells adjusted to 1 X 106/ml in RPMI 1640 plus 20% FCS were incubated with PWM, as described above, and anti-RCRI antibodies at 10 ug/ml for 5 d at 370C, 5% CO2 in air before harvesting. Resulting plasma cells were stained for total plasma cell and RCRI positive plasma cell numbers.
Synovial cell preparation. Synovial tissue was teased with forceps to liberate imbedded plasma cells. The resultant cell preparation was adjusted to 1 X 106 cells/ml in Hanks' balanced salt solution before preparing cytocentrifuge slides.
Preparation of cryostat sections of peripheral blood PWM-induced plasma cells. Peripheral blood, PWM-induced plasma cells from patient Glo (member, Wa group), were pelleted at 200 g for 10 min at 4°C. A 0.5-cm3 layer of Ames O.C.T. compound (Miles Laboratories) was placed on top of the cell pellet and then frozen in a methanol, dry ice snap-freezing mixture. Frozen cells were kept at -70°C until 4-,um cryostat sections were made.
Cryostat sections were fixed in cold acetone for 10 min and then washed for 15 min in PBS 0.01 M, pH 7.2, before staining the cells in indirect and direct immunofluorescence.
Waaler-Rose hemagglutination assay for RF. Washed sheep erythrocytes were coupled with purified human IgG with glutaraldehyde as previously described (10) . Aliquots of sera, 20 Ml/well, were titrated over 48 dilutions in PBS 0.01 M, pH 7.2, with 1% absorbed FCS before human IgGcoated sheep erythrocytes were added.
Latex fixation by rheumatoid sera. Latex particles coated with purified human IgG (Hyland Laboratories, Costa Mesa, CA) as described previously (11) were used to measure RF titer of the various rheumatoid sera.
Monoclonal IgM reduction and alkylation. Reduction and alkylation of monoclonal IgM from patient Glo was performed as described previously (12) . In short, IgM preparations were reduced by dialysis against 0.1 M mercaptoethanol (Eastman Chemicals, Rochester, NY) in sodium phosphate, pH 7.5 buffer, 0.2 tonic strength. Dialysis was allowed to proceed for 3 h at room temperature with stirring of the ethyl mercaptan solution. At the end of the dialysis period, the dissociated samples were either alkylated in order to prevent spontaneous reassociation or allowed to reassociate by removal of the ethyl mercaptan by dialysis. Alkylation was effected by dialysis against a large volume of 0.02 M monoiodoacetamide ( 5-19% of all cells (Table II) ; there was considerable variation among different individuals, but no significant difference between the rheumatoid and the control groups. The frequency of IgM-containing cells was measured in the cultures of two RA patients and was found to be 64.3 and 62.0 per 100 immunoglobulincontaining cells, a finding comparable to that of 57.2 and 55.3 detected in two controls.
A striking difference between RA patients and controls was found when examining the frequency, in 5-d PWM cultures, of cells containing the RCRI. This was found (Table II) in 10.6-18% of plasma cells in RA patients, a frequency more than fivefold higher than that of 1.5-2.8% found in cultures of normal individuals.
These data are supplemented and qualified by the following facts: (a) The final absorption of the anti- These data require some technical comments. First, it is clear that the penetration of aggregated IgG in the cytoplasm of ethanol-fixed cells can be obtained since the proportion of aggregate-binding cells in our cytocentrifuge preparation is not basically different from that reported by others (14) for cryostat-cut sections of active rheumatoid synovial lesions.
Secondly, the possibility that staining with anti-RCRI antibodies was due to RF-containing cells reacting with immune complexes in the anti-RCRI preparation requires consideration. This possibility, negligible in the case of PWM-stimulated cells from the peripheral blood that showed no aggregate binding, arose again for the cells from the synovial tissues. However, the same results were obtained with anti-RCRI preparations treated only with solid absorbents and therefore presumably not containing immune complexes; in addition, there were definitely more idiotype positive than aggregate binding cells.
In the third place, the possibility of competition between the binding of aggregated IgG and that of anti-RCRI antibodies must be considered. In fact, this competition has been shown to occur in solution (15) .
In this respect, the sequence of staining, with aggregates first, may have inhibited the binding of the anti-RCRI antibodies, but the reverse could not have happened. Actually, the antiidiotype staining of the cells that had bound the aggregates was often less intensive than that of the nonaggregate binding ones. However, the number of cells that stained with aggregates and not at all with the antiidiotype was low and certainly not higher than the one expected for RCRI-negative rheumatoid clones, indicating that probably aggregate binding did not completely block the antiidiotype binding in any cell; the possible reason for this is discussed later and may be due to the presence in the cytoplasm of some cells of an aliquot of molecules (IgM monomers) that do not form a stable bond with aggregated IgG, but still fully express the RCRI determinants.
DISCUSSION
The present observations indicate that the PBL of RA patients show a large number of plasma cells after PWM stimulation that bear the CRI previously demonstrated for many monoclonal RF. The number was much larger than for similarly stimulated cells from normal individuals and the intensity of fluorescent staining was considerably greater. It was evident that the degree of absorption of the cross-idiotypic antiserum was of special importance in a cellular study of this type. However, it was of interest that even under conditions of minimal absorption the contrast between the RA and normal plasma cells was obvious (Fig. 1) (19, 20, 21) . In human 19 S IgM secreting tumors, the proportion of intracellular pentamer varied in different cases (22) , but no data are available on PWM-stimulated cells that may be relatively immature plasma cells. It is known that these cells express Ia determinants and surface immunoglobulins that are absent from mature plasma cells (23) .
We have found that the majority of these RF-containing cells react strongly with antibodies specific for the CRI of the monoclonal cryoglobulins of the major Wa group. This observation supports the concept that the polyclonal RF produced in RA are idiotypically related to the monoclonal RF observed in cryoglobulinemias of the mixed type. In this respect, the human RF system appears to be similar to other antibody systems in which immunoglobulins that react with the 3 Tonda, P., and B. Pernis. Conditions for the demonstration of antigen binding by cytoplasmic immunofluorescence in plasma cell slides. Submitted for publication. 4 In fact these anti-IgG antibodies have been shown (6) to have a CRI that is shared with monoclonal antibodies produced by hybridomas that react with different determinants of the same allotype. It is therefore possible to understand the presence of common idiotypic determinants in the cryoglobulins of the Wa group and in plasma cells of rheumatoid lesions, that are presumably quite heterogeneous with regard to the specificity of the RF that they produce, corresponding to the different specificities found in rheumatoid sera (15) . In addition to the cells that bound aggregated IgG and the antibodies directed against the CRI of the Wa cryoglobulin, the synovial tissue contained other aggregate-binding cells. These may have been producing RF idiotypically related to the other cross-idiotypic groups of cryoglobulins (25); we are currently investigating this possibility.
The process of maturation to RCRI-containing plasma cells could be inhibited in a specific fashion by the addition of small amounts of anti-RCRI antibodies to the cultures. This is clearly the consequence of an interaction of the antibodies with the membrane idiotypes of the precursor lymphocytes; it is similar to the suppression of other idiotypes in culture, by consequence of the addition of the corresponding antibodies, as reported by Mudawwar and by Bona and Fauci (25, 26) .
A final remark concerns the immunofluorescence detection of RF. This procedure has been useful in the study of RA and has relied so far on the use of fluorochrome-conjugated aggregated IgG, introduced by Mellors in 1959 (27) . However, it appears that this reagent detects extracellular RF (including those of germinal centers) that are pentameric molecules, but that it may fail to identify intracytoplasmic rheumatoid factors in many cells or clones of cells; certainly the aggregated IgG does not detect intracytoplasmic RF in plasma cells obtained by PWM cultures of PBL. It appears from the present work that the use of antibodies to the Idx of RF is of special value in cellular studies of RA, mixed cryoglobulinemia and related diseases. Monoclonal antibodies of this specificity would be particularly useful; our current efforts are directed at obtaining such reagents.
